{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T17:51:01Z","timestamp":1716832261959},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2007,11,9]],"date-time":"2007-11-09T00:00:00Z","timestamp":1194566400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1007\/s00228-007-0394-1","type":"journal-article","created":{"date-parts":[[2007,11,8]],"date-time":"2007-11-08T18:33:26Z","timestamp":1194546806000},"page":"303-309","source":"Crossref","is-referenced-by-count":21,"title":["Identification of severe potential drug-drug interactions using an Italian general-practitioner database"],"prefix":"10.1007","volume":"64","author":[{"given":"L.","family":"Magro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Conforti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Del Zotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Leone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. L.","family":"Iorio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Meneghelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Massignani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Vison\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Moretti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,11,9]]},"reference":[{"key":"394_CR1","volume-title":"Drug interaction facts\u2122-the authority on drug interactions","author":"DS Tatro","year":"2006","unstructured":"Tatro DS (ed) (2006) Drug interaction facts\u2122\u2014the authority on drug interactions. Facts and Comparisons, St. Louis, MO"},{"issue":"1","key":"394_CR2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s002280050330","volume":"53","author":"PE Gr\u00f6nroos","year":"1997","unstructured":"Gr\u00f6nroos PE, Irjala KM, Huupponen RK, Scheinin H, Forsstr\u00f6m J, Forsstr\u00f6m JJ (1997) A medication database-a tool for detecting drug interactions in hospital. Eur J Clin Pharmacol 53(1):13\u201317","journal-title":"Eur J Clin Pharmacol"},{"issue":"9","key":"394_CR3","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s00228-005-0978-6","volume":"61","author":"B Glintborg","year":"2005","unstructured":"Glintborg B, Andersen SE, Dalhoff K (2005) Drug-drug interactions among recently hospitalized patients-frequent but mostly clinically insignificant. Eur J Clin Pharmacol 61(9):675\u2013681","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"394_CR4","first-page":"427","volume":"9","author":"JM Cruciol-Souza","year":"2006","unstructured":"Cruciol-Souza JM, Thomson JC (2006) Prevalence of potential drug-drug interactions and its associated factors in a Brazilian teaching hospital. J Pharm Pharm Sci 9(3):427\u2013433","journal-title":"J Pharm Pharm Sci"},{"issue":"3","key":"394_CR5","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/02813430310001806","volume":"21","author":"L Bjerrum","year":"2003","unstructured":"Bjerrum L, Andersen M, Petersen G, Kragstrup J (2003) Exposure to potential drug interactions in primary health care. Scand J Prim Health Care 21(3):153\u2013158","journal-title":"Scand J Prim Health Care"},{"issue":"10","key":"394_CR6","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1177\/106002809002401014","volume":"24","author":"CA Jankel","year":"1990","unstructured":"Jankel CA, Speedie SM (1990) Detecting drug interactions: a review of the literature. DICP 24(10):982\u2013989","journal-title":"DICP"},{"issue":"11","key":"394_CR7","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1345\/aph.1A484","volume":"36","author":"IK Bj\u00f6rkman","year":"2002","unstructured":"Bj\u00f6rkman IK, Fastbom J, Schmidt IK, Bernsten CB, Pharmaceutical Care of the Elderly in Europe Research (PEER) Group (2002) Drug-drug interactions in the elderly. Ann Pharmacother 36(11):1675\u20131681","journal-title":"Ann Pharmacother"},{"issue":"5","key":"394_CR8","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/BF01879709","volume":"17","author":"L Bergendal","year":"1995","unstructured":"Bergendal L, Friberg A, Schaffrath A (1995) Potential drug-drug interactions in 5,125 mostly elderly out-patients in Gothenburg, Sweden. Pharm World Sci 17(5):152\u2013157","journal-title":"Pharm World Sci"},{"issue":"3","key":"394_CR9","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/fampra\/8.3.234","volume":"8","author":"AJ Costa","year":"1991","unstructured":"Costa AJ (1991) Potential drug interactions in an ambulatory geriatric population. Fam Pract 8(3):234\u2013236","journal-title":"Fam Pract"},{"issue":"2","key":"394_CR10","first-page":"210","volume":"45","author":"JU Rosholm","year":"1998","unstructured":"Rosholm JU, Bjerrum L, Hallas J, Worm J, Gram LF (1998) Polypharmacy and the risk of drug-drug interactions among Danish elderly. A prescription database study. Dan Med Bull 45(2):210\u2013213","journal-title":"Dan Med Bull"},{"issue":"12","key":"394_CR11","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s00228-003-0709-9","volume":"59","author":"L Gu\u00e8don-Moreau","year":"2004","unstructured":"Gu\u00e8don-Moreau L, Ducrocq D, Duc MF, Quieureux Y, L\u2019H\u00f4te C, Deligne J, Caron J (2004) Absolute contraindications in relation to potential drug interactions in outpatient prescriptions: analysis of the first five million prescriptions in 1999. Eur J Clin Pharmacol 59(12):899\u2013904","journal-title":"Eur J Clin Pharmacol"},{"issue":"9","key":"394_CR12","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s00228-006-0143-x","volume":"62","author":"B Astrand","year":"2006","unstructured":"Astrand B, Astrand E, Antonov K, Petersson G (2006) Detections of potential drug interactions-a model for a national pharmacy register. Eur J Clin Pharmacol 62(9):749\u2013756","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"394_CR13","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1136\/hrt.38.2.167","volume":"38","author":"E Steiness","year":"1976","unstructured":"Steiness E, Olesen KH (1976) Cardiac arrhythmias induced by hypokalaemia and potassium loss during maintenance digoxin therapy. Br Heart J 38(2):167\u2013172","journal-title":"Br Heart J"},{"issue":"6","key":"394_CR14","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0002-9343(01)00642-8","volume":"110","author":"H Schepkens","year":"2001","unstructured":"Schepkens H, Vanholder R, Billiouw JM, Lameire N (2001) Life-threatening hyperkalemia during combined therapy with angiotensin-converting enzyme inhibitors and spironolactone: an analysis of 25 cases. Am J Med 110(6):438\u2013441","journal-title":"Am J Med"},{"issue":"6","key":"394_CR15","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.1365-2710.2005.00688.x","volume":"30","author":"B Janchawee","year":"2005","unstructured":"Janchawee B, Owatranporn T, Mahatthanatrakul W, Chongsuvivatwong V (2005) Clinical drug interactions in outpatients of a university hospital in Thailand. J Clin Pharm Ther 30(6):583\u2013590","journal-title":"J Clin Pharm Ther"},{"issue":"11","key":"394_CR16","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s00228-002-0557-z","volume":"58","author":"SS Egger","year":"2003","unstructured":"Egger SS, Drewe J, Schlienger RG (2003) Potential drug-drug interactions in the medication of medical patients at hospital discharge. Eur J Clin Pharmacol 58(11):773\u2013778","journal-title":"Eur J Clin Pharmacol"},{"issue":"6","key":"394_CR17","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/pds.1351","volume":"16","author":"ML Becker","year":"2006","unstructured":"Becker ML, Kallewaard M, Caspers PW, Visser LE, Leufkens HG, Stricker BH (2006) Hospitalisations and emergency department visits due to drug-drug interactions: a literature review. Pharmacoepidemiol Drug Saf 16(6):641\u2013651","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"8","key":"394_CR18","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1111\/j.1532-5415.1996.tb01865.x","volume":"44","author":"J Doucet","year":"1996","unstructured":"Doucet J, Chassagne P, Trivalle C, Landrin I, Pauty MD, Kadri N, M\u00e8nard JF, Bercoff E (1996) Drug-drug interactions related to hospital admissions in older adults: a prospective study of 1000 patients. J Am Geriatr Soc 44(8):944\u2013948","journal-title":"J Am Geriatr Soc"},{"issue":"9","key":"394_CR19","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1345\/aph.1A333","volume":"36","author":"PJ McDonnell","year":"2002","unstructured":"McDonnell PJ, Jacobs MR (2002) Hospital admissions resulting from preventable adverse drug reactions. Ann Pharmacother 36(9):1331\u20131336","journal-title":"Ann Pharmacother"},{"issue":"6","key":"394_CR20","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1365-2125.2006.02809.x","volume":"63","author":"AI Vitry","year":"2006","unstructured":"Vitry AI (2006) Comparative assessment of four drug interaction compendia. Br J Clin Pharmacol 63(6):709\u2013714","journal-title":"Br J Clin Pharmacol"},{"key":"394_CR21","unstructured":"Il Pensiero Scientifico (Ed) (2005) L\u2019uso dei Farmaci in Italia-Rapporto Nazionale anno 2004. OsMed (Osservatorio Nazionale sull\u2019Impiego dei Medicinali), Rome"},{"issue":"11","key":"394_CR22","doi-asserted-by":"crossref","first-page":"539","DOI":"10.5414\/CPP44539","volume":"44","author":"R Fux","year":"2006","unstructured":"Fux R, Greiner D, Geldmacher M, M\u00f6rike K, Gleiter CH (2006) Multiple drug prescribing by general practitioners in a German region: implications for drug interactions and patient safety. Int J Clin Pharmacol Ther 44(11):539\u2013547","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"8","key":"394_CR23","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1056\/NEJM199702203360801","volume":"336","author":"The Digitalis Investigation Group","year":"1997","unstructured":"The Digitalis Investigation Group (1997) The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 336(8):525\u2013533","journal-title":"N Engl J Med"},{"issue":"2","key":"394_CR24","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/eurheartj\/ehi687","volume":"27","author":"A Ahmed","year":"2006","unstructured":"Ahmed A, Rich MW, Love TE, Lloyd-Jones DM, Aban IB, Colucci WS, Adams KF, Gheorghiade M (2006) Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial. Eur Heart J 27(2):178\u2013186","journal-title":"Eur Heart J"},{"issue":"6","key":"394_CR25","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2005.08.022","volume":"46","author":"SA Hunt","year":"2005","unstructured":"Hunt SA, American College of Cardiology, American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure) (2005) ACC\/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 46(6):e1\u2013e82","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"394_CR26","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/S0735-1097(02)01708-4","volume":"39","author":"KF Adams","year":"2002","unstructured":"Adams KF, Gheorghiade M, Uretsky BF, Patterson JH, Schwartz TA, Young JB (2002) Clinical benefits of low serum digoxin concentrations in heart failure. J Am Coll Cardiol 39(6):946\u2013953","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"394_CR27","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1001\/archinte.1985.00360040073017","volume":"145","author":"R Whang","year":"1985","unstructured":"Whang R, Oei TO, Watanabe A (1985) Frequency of hypomagnesaemia in hospitalized patients receiving digitalis. Arch Inter Med 145(4):655\u2013656","journal-title":"Arch Inter Med"},{"issue":"4","key":"394_CR28","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/clpt.1983.55","volume":"33","author":"GG Belz","year":"1983","unstructured":"Belz GG, Doering W, Munkes R, Matthews J (1983) Interaction between digoxin and calcium antagonists and antiarrhythmic drugs. Clin Pharmacol Ther 33(4):410\u2013417","journal-title":"Clin Pharmacol Ther"},{"issue":"40","key":"394_CR29","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1055\/s-0028-1129302","volume":"103","author":"HU Lehmann","year":"1978","unstructured":"Lehmann HU, Witt E, Temmen L, Hochrein H (1978) Life-threatening digitalis intoxication with and without additional diuretic treatment. Dtsch Med Wochenschr 103(40):1566\u20131571","journal-title":"Dtsch Med Wochenschr"},{"issue":"4","key":"394_CR30","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1053\/pcad.2002.31591","volume":"44","author":"EJ Eichhorn","year":"2002","unstructured":"Eichhorn EJ, Gheorghiade M (2002) Digoxin. Prog Cardiovasc Dis 44(4):251\u2013266","journal-title":"Prog Cardiovasc Dis"},{"issue":"5","key":"394_CR31","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/0033-0620(84)90012-4","volume":"26","author":"TW Smith","year":"1984","unstructured":"Smith TW, Antman EM, Friedman PL, Blatt CM, Marsh JD (1984) Digitalis glycosides: mechanism and manifestations of toxicity. Parts I and II. Prog Cardiovasc Dis 26(5):413\u2013458; 26 (6):495\u2013540","journal-title":"Prog Cardiovasc Dis"},{"issue":"1","key":"394_CR32","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1378\/chest.86.1.75","volume":"86","author":"WJ Oetgen","year":"1984","unstructured":"Oetgen WJ, Sobol SM, Tri TB, Heydon WH, Rakita L (1984) Amiodarone-digoxin interaction. Clinical and experimental observations. Chest 86(1):75\u201379","journal-title":"Chest"},{"issue":"1","key":"394_CR33","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0735-1097(84)80327-7","volume":"4","author":"K Nademanee","year":"1984","unstructured":"Nademanee K, Kannan R, Hendrickson J, Ookhtens M, Kay I, Singh BN (1984) Amiodarone-digoxin interaction: clinical significance, time course of development, potential pharmacokinetic mechanisms and therapeutic implications. J Am Coll Cardiol 4(1):111\u2013116","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"394_CR34","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/clpt.1983.121","volume":"34","author":"KE Pedersen","year":"1983","unstructured":"Pedersen KE, Christiansen BD, Kjaer K, Klitgaard NA, Nielsen-Kudsk F (1983) Verapamil-induced changes in digoxin kinetics and intraerythrocytic sodium concentration. Clin Pharmacol Ther 34(1):8\u201313","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"394_CR35","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1161\/01.CIR.65.6.1163","volume":"65","author":"JB Schwartz","year":"1982","unstructured":"Schwartz JB, Keefe D, Kates RE, Kirsten E, Harrison DC (1982) Acute and chronic pharmacodynamic interaction of verapamil and digoxin in atrial fibrillation. Circulation 65(6):1163\u20131170","journal-title":"Circulation"},{"issue":"5","key":"394_CR36","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1161\/01.CIR.65.5.998","volume":"65","author":"HO Klein","year":"1982","unstructured":"Klein HO, Lang R, Weiss E, Di Segni E, Libhaber C, Guerriero J, Kaplinsky E (1982) The influence of verapamil on serum digoxin concentration. Circulation 65(5):998\u20131003","journal-title":"Circulation"},{"issue":"2","key":"394_CR37","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2165\/00002018-199512020-00003","volume":"12","author":"B Magnani","year":"1995","unstructured":"Magnani B, Malini PL (1995) Cardiac glycosides. Drug interactions of clinical significance. Drug Saf 12(2):97\u2013109","journal-title":"Drug Saf"},{"issue":"7407","key":"394_CR38","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1136\/bmj.327.7407.147","volume":"327","author":"E Wrenger","year":"2003","unstructured":"Wrenger E, M\u00fcller R, Moesenthin M, Welte T, Fr\u00f6lich JC, Neumann KH (2003) Interaction of spironolactone with ACE-inhibitors or angiotensin receptor blockers: analysis of 44 cases. BMJ 327(7407):147\u2013149","journal-title":"BMJ"},{"issue":"1","key":"394_CR39","first-page":"23","volume":"139","author":"DW Simborg","year":"1976","unstructured":"Simborg DW (1976) Medication prescribing on a university medical service-the incidence of drug combinations with potential adverse interactions. Johns Hopkins Med J 139(1):23\u201326","journal-title":"Johns Hopkins Med J"},{"issue":"2","key":"394_CR40","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0167-5273(92)90159-Z","volume":"34","author":"RT Johnston","year":"1992","unstructured":"Johnston RT, de Bono DP, Nyman CR (1992) Preventable sudden death in patients receiving angiotensin converting enzyme inhibitors and loop\/potassium sparing diuretic combinations. Int J Cardiol 34(2):213\u2013215","journal-title":"Int J Cardiol"},{"issue":"1","key":"394_CR41","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1001\/archinte.158.1.26","volume":"158","author":"LC Reardon","year":"1998","unstructured":"Reardon LC, Macpherson DS (1998) Hyperkalemia in outpatients using angiotensin-converting enzyme inhibitors. Arch Intern Med 158(1):26\u201332","journal-title":"Arch Intern Med"},{"issue":"2","key":"394_CR42","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/01.md.0000123095.65294.34","volume":"83","author":"D Kurnik","year":"2004","unstructured":"Kurnik D, Loebstein R, Farfel Z, Ezra D, Halkin H, Olchovsky D (2004) Complex drug-drug-disease interactions between amiodarone, warfarin, and the thyroid gland. Medicine (Baltimore) 83(2):107\u2013113","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"394_CR43","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2165\/00002018-200023030-00003","volume":"23","author":"JA Farmer","year":"2000","unstructured":"Farmer JA, Torre-Amione G (2000) Comparative tolerability of the HMG-CoA reductase inhibitors. Drug Saf 23(3):197\u2013213","journal-title":"Drug Saf"},{"issue":"4","key":"394_CR44","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1046\/j.1365-2125.2000.00261.x","volume":"50","author":"JF Westphal","year":"2000","unstructured":"Westphal JF (2000) Macrolide-induced clinically relevant drug interactions with cytochrome P-450A (CYP) 3A4: an update focused on clarithromycin, azithromycin and dirithromycin. Br J Clin Pharmacol 50(4):285\u2013295","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"394_CR45","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1128\/AAC.35.6.1186","volume":"35","author":"DE Amacher","year":"1991","unstructured":"Amacher DE, Schomaker SJ, Retsema JA (1991) Comparison of the effects of the new azalide antibiotic, azithromycin, and erythromycin estolate on rat liver cytochrome P-450. Antimicrob Agents Chemother 35(6):1186\u20131190","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl","key":"394_CR46","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/jac\/37.suppl_C.133","volume":"37","author":"M Nahata","year":"1996","unstructured":"Nahata M (1996) Drug interactions with azithromycin and the macrolides; an overview. J Antimicrobic Chemother 37(Suppl):133\u2013142","journal-title":"J Antimicrobic Chemother"},{"issue":"8","key":"394_CR47","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00228-005-0972-z","volume":"61","author":"N Piacentini","year":"2005","unstructured":"Piacentini N, Trifir\u00f2 G, Tari M, Moretti S, Arcoraci V, UVEC Group (2005) Statin-macrolide interaction risk: a population-based study throughout a general practice database. Eu J Clin Pharmacol 61(8):615\u2013620","journal-title":"Eu J Clin Pharmacol"},{"issue":"1","key":"394_CR48","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/01.mjt.0000208875.61480.c8","volume":"14","author":"P Stang","year":"2007","unstructured":"Stang P, Morris L, Kempf J, Henderson S, Yood MU, Oliveria S (2007) The coprescription of contraindicated drugs with statins: continuing potential for increased risk of adverse events. Am J Ther 14(1):30\u201340","journal-title":"Am J Ther"},{"issue":"12","key":"394_CR49","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1097\/00005650-200212000-00004","volume":"40","author":"PA Glassman","year":"2002","unstructured":"Glassman PA, Simon B, Belperio P, Lanto A (2002) Improving recognition of drug interactions: benefits and barriers to using automated drug alerts. Med Care 40(12):1161\u20131171","journal-title":"Med Care"},{"issue":"3","key":"394_CR50","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1023\/A:1024077018902","volume":"25","author":"PD Hansten","year":"2003","unstructured":"Hansten PD (2003) Drug interaction management. Pharm World Sci 25(3):94\u201397","journal-title":"Pharm World Sci"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-007-0394-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-007-0394-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-007-0394-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T12:51:44Z","timestamp":1558702304000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-007-0394-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11,9]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["394"],"URL":"https:\/\/doi.org\/10.1007\/s00228-007-0394-1","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,11,9]]}}}